China Automotive Systems Inc (CAAS) reports a robust 11.1% sales increase, driven by EPS demand, despite facing margin ...

Aquestive Therapeutics (AQST) has priced an underwritten offering of 21.25M shares at $4.00 each, expecting $85M in gross proceeds.

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results have been mostly positive.